Repligen to Participate in 15th Annual Craig-Hallum Institutional Investor Conference
Repligen Corporation (RGEN)
Last repligen corporation earnings: 2/20 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
repligen.com/investors
Company Research
Source: GlobeNewswire
WALTHAM, Mass., May 17, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a leading life sciences company focused on bioprocessing technology leadership, today announced that Jon K. Snodgres, Chief Financial Officer, will participate in the 15th Annual Craig-Hallum Institutional Investor Conference, being held on May 30th in Minneapolis. The conference is a series of one-on-one meetings with investors and does not include a formal presentation. An updated investor presentation can be accessed on the event date by visiting the Investor Relations section of the Repligen Corporation website at www.repligen.com. About Repligen CorporationRepligen Corporation (NASDAQ:RGEN) is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Our portfolio includes Protein products (Protein A affinity ligands, cell culture growth factors), Chromatography products (OPU
Show less
Read more
Impact Snapshot
Event Time:
RGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGEN alerts
High impacting Repligen Corporation news events
Weekly update
A roundup of the hottest topics
RGEN
News
- Should be Confident in Repligen Corporation (RGEN)'s Long-Term Growth Potential? [Yahoo! Finance]Yahoo! Finance
- Danaher gains as Q1 results exceed expectations [Seeking Alpha]Seeking Alpha
- Repligen to Report First Quarter 2024 Financial ResultsGlobeNewswire
- Global Upstream Bioprocessing Market Projected to Reach $25 Billion by 2030 - Analysis by Product Type, Workflow, Usage Type, Mode, and Region [Yahoo! Finance]Yahoo! Finance
- Repligen Appoints Maggie A. Pax to Board of Directors [Yahoo! Finance]Yahoo! Finance
RGEN
Earnings
- 2/21/24 - In-Line
RGEN
Sec Filings
- 4/4/24 - Form 4
- 4/1/24 - Form ARS
- 4/1/24 - Form DEFA14A
- RGEN's page on the SEC website